ovo Nordisk is investing around US$182 million in two new office buildings in Bagsværd, Denmark. The buildings will house Novo Nordisk's top management, 1,100 administrative employees and a number of shared facilities.
CSI Labs has opened its new headquarters in Alpharetta, Ga. CSI specializes in analyzing patient biopsies from across the U.S. The company, formed in 1997, employs 170 at its headquarters.
GMU Builds New Life Sciences Center
George Mason University has broken ground for a new life sciences building at its Prince William Campus. GMU is erecting a 75,354-sq.-ft. (7,000-sq.-m.) laboratory building. The new life sciences building will expand the current research facilities and offer more opportunities for collaboration and program growth. The building will serve as the new home to Mason's Center for Applied Proteomics and Molecular Medicine, a nationally recognized center that studies the behavior of microscopic proteins. The second life sciences building of its type on the campus, this building is planned to include wet lab space available for commercial lease as well as laboratories to house university research programs. The projected cost of the facility is $30 million, and it is expected to be completed by spring 2013.
The Advanced Medical Technology Association (AdvaMed) has released a study that finds that the new medical device excise tax could cost thousands of jobs. The new study, "Employment Effects of the New Excise Tax on the Medical Device Industry," by Manhattan Institute senior fellow Diana Furchtgott-Roth and Hudson Institute senior fellow Harold Furchtgott-Roth, outlines a number of economic harms likely to result from the tax.
Québec-based Medicago has begun operations at its new vaccine facility in North Carolina.
The National Institutes of Health announced that it is awarding $143.8 million to challenge the status quo with innovative ideas that have the potential to propel fields forward and speed the translation of research into improved health for the American public.
These awards are granted under three innovative research programs supported by the NIH Common Fund: the NIH Director's Pioneer, New Innovator, and Transformative Research Projects Awards. The Common Fund, enacted into law by Congress through the 2006 NIH Reform Act, supports trans-NIH programs with a particular emphasis on innovation and risk taking.
"The NIH Director's Award programs reinvigorate the biomedical work force by providing unique opportunities to conduct research that is neither incremental nor conventional," said James M. Anderson, M.D., Ph.D., director of the Division of Program Coordination, Planning and Strategic Initiatives, who guides the Common Fund's High-Risk Research program. "The awards are intended to catalyze giant leaps forward for any area of biomedical research, allowing investigators to go in entirely new directions."
Illinois Gov. Pat Quinn has signed a memorandum of cooperation between life sciences organizations in his state and a Chinese pharmaceutical group aimed at developing life sciences business and education partnerships.